Unlike traditional MSPs or MSSPs, JSOC IT doesn’t operate at arm’s length. Instead, it embeds directly with client teams to audit, optimize, and integrate their technology stacks — turning fragmented ...
In a keynote speech delivered at the SEMICON Taiwan 2025, NXP CEO Kurt Sievers stressed that AI has ushered the semiconductor industry into a period of exponential expansion. Addressing the future of ...
ABSTRACT: Prioritizing public transport is crucial for sustainable urban development on a global scale, yet it faces challenges from emerging mobility services and socioeconomic changes following the ...
NEW YORK, Aug 22 (Reuters) - Nike's (NKE.N), opens new tab push into the booming outdoor recreation market — which will kick off on Monday with the launch of a new trail running shoe — will test ...
Each year, Justin Lindholm uses about two-and-a-half gallons of gasoline to get through the winter. It’s just enough, he said, to power his chainsaw to chop the four to five cords of logs that fuel ...
Tesla has introduced a new, longest-range model, a variant of the Model 3 with 830 km (515 miles) of range, but it is currently planned only for the Chinese market. Last month, we reported on Tesla ...
Grocery tech company posts a 17% gain in orders during Q2, as CEO Fidji Simo is set to depart As she exits, Simo shared her thoughts on the company’s position for the future. “We have an exceptional ...
Jeff Fenster is the epitome of an entrepreneur. The Everbowl founder lived many lives before he started the acai bowl concept in 2016, launching and selling multiple companies. Then, like a true ...
Baxter's restructuring created a more focused, profitable business, but growth prospects are limited and already reflected in the stock's valuation. Competitive pressures, high debt, and lack of ...
A new AI tool trained on real microscopy data simulates nanoparticle movement with high accuracy, helping scientists decode atomic-scale behavior in complex environments. (Nanowerk News) Nanoparticles ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback